Latest Stock Market News

Cryptocurrencies are believed to provide a solution to the limitations of traditional financial systems in our increasingly borderless world. Digital currencies have shattered convention, leaving an indelible mark on the financial markets, worldwide

As Q1 earnings are ​underway, a host of brokerages upgraded the target price on a number of scrips.

Ebitda grew over 205% on a year-on-year basis to approximately Rs 700 crores. "Ebitda margin saw a significant improvement of around 3100 basis points, reaching 77%, due to reduced operating costs and internal consumption," the company said in a press statement.

A total of 670 shares changed hands on the counter till 12:13PM (IST)

The Director General of Civil Aviation (DGCA) on Friday, July 28, re-issued the Air Operator Certificate (AOC) which expired on May 19, 2023, as the airline did not start operations after getting an AOC from the DGCA on May 20, 2022, PTI reported.

Those selling shares in the OFS are promoter Pawan Kumar Gupta and existing shareholders -- Glentrade DMCC, Ramesh Girdharilal Lulla, Rahul Porwal, Pankaj Jain, Piyush Dungarpuria and R Sambhu Kumar.

As of 30-Jun-2023, promoters held 74.36 per cent stake in the company, while FIIs held 15.3 per cent and domestic institutional investors had 3.44 per cent.

Domestic brokerage firm ICICI Securities reiterated its Buy rating on the stock with a target price of Rs 850, which indicates an upside potential of 24% from the current market prices.

The pharmaceutical sector in India is showing strong domestic growth of 7% to 9%, despite flat global growth in the US and Europe, according to pharma expert Kewal Handa. He sees good opportunities for Indian companies in the US, as a significant number of patents are set to expire in the next five years. Biosimilars and the application of artificial intelligence in R&D are expected to be major growth areas, and Handa predicts double-digit growth next year.

The Relative Strength Index of the stock stood at 77.98 on Monday.